Emitof-4 Tablet
Ondansetron 4 mg
Product Key Facts
Gastro-intestinal
Medications that support digestive health and help manage conditions like acid reflux, stomach ulcers, or constipation.
Digestive System Health
Digestive system medications, ranging from antacids and antiemetics to laxatives and probiotics, address conditions such as acid reflux, nausea, constipation, and bacterial infections. Professional guidance is essential for accurate diagnosis and proper use of these medications.
Details at a Glance
| Product Code | : | 1084 |
| Pack Size | : | 3x10's |
| MRP | : | ৳ 150 |
Specifications
Emitof-4 Tablet belongs to the gastro-intestinal therapeutic class and is formulated as an antiemetic medication. Each tablet of Emitof-4 contains 4 mg of Ondansetron, an active ingredient that belongs to a class of drugs known as serotonin 5-HT3 receptor antagonists. The medication is packaged in a size of 3 x 10 tablets, offering a total of 30 tablets per pack.
Emitof-4 Tablet, with Ondansetron 4 mg as its active component, is primarily indicated for the prevention and treatment of nausea and vomiting. This includes nausea and vomiting caused by chemotherapy, radiation therapy, and postoperative nausea and vomiting. Ondansetron works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
The dosage of Emitof-4 Tablet should be prescribed based on the specific condition being treated, the patient's age, and overall medical condition. For the prevention of nausea and vomiting associated with chemotherapy and radiation therapy, the usual adult dose is 8 mg administered 30 minutes before treatment, followed by subsequent doses as prescribed. For the prevention of postoperative nausea and vomiting, the typical dose is 4 mg taken 1 hour before the end of surgery.
Patients are advised to take Emitof-4 Tablet exactly as prescribed by their healthcare provider. It can be taken with or without food. If a dose is missed, it should be taken as soon as possible; however, if it is almost time for the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. Double dosing should be avoided.
It's important for patients to be aware that while Emitof-4 Tablet can help manage nausea and vomiting, it may not completely prevent these symptoms in all cases. Patients should inform their healthcare provider of all medications they are currently taking, as there may be potential interactions. Additionally, any side effects or unusual symptoms experienced while taking Emitof-4 should be reported to a healthcare professional.
